Michael Thien (Moderator)
Former, SVP & Head of Pharmaceutical Sciences, R&D
Takeda
Pat Yang
Chairman
Taiwan BioManufacturing Corp (TBMC)
Ran Zheng
Chief Executive Officer
Landmark Bio
Details:
- Developing innovative strategies to support development of medications for rare and ultra-rare diseases
- Discussing strategies to integrate digital tools and automation for faster, more resilient biomanufacturing processes
- Exploring ways to foster cross-functional innovation amid evolving regulatory and supply chain challenges
